Letter from the Board
We are so pleased to welcome four of radiation oncology’s best and brightest research teams to the inspiring group of investigators supported by the ROI. All of these new grants are focused on personalizing radiation therapy by tailoring care to each patient’s unique characteristics. The ROI selected these projects from many great proposals because of their potential to have a lasting impact on practice and improve care and outcomes for patients being treated with radiation therapy. The ROI Research Committee, led by Gita Suneja, MD, MS, and Robert C. Miller, MD, MBA, FASTRO, did a fantastic job developing the request for proposals that was relevant to the work of so many in the field and identifying the award winners through a rigorous peer-review process.
Each of the new research teams and their projects are featured on the ROI website and we invite you to learn more about all of them.
- Carmen Bergom, MD, PhD, and El-Sayed Ibrahim, PhD, and their team at the Medical College of Wisconsin are conducting a pilot study to determine whether advanced cardiac MRI can be used to detect early, non-symptomatic damage to the heart in lung cancer patients treated with radiation therapy.
- David Byun, MD, in collaboration with Kevin Du, MD, and Gregory Dorsainville, MPS, at NYU Langone Health’s Perlmutter Cancer Center, is exploring whether the application of virtual and augmented reality platforms during consultation visits could better increase patient knowledge about radiation therapy, reduce anxiety, and improve the quality of their overall treatment experience.
- Daniel Golden, MD, MHPE, and Ritu Arya, MD, at the University of Chicago are focused on improving communication between patients with cancer and their physicians by developing personalized discussion guides that explain external beam radiotherapy in an easy-to-digest format.
- Adam Wolfe, MD, PhD, and Terence Williams, MD, PhD, and their team at The Ohio State University are working to identify which pancreatic cancer patients could benefit the most from radiation therapy following surgery using a new molecular signature that they discovered and is made up of microRNAs found in blood and tumor tissue samples.
Outstanding research projects such as these are only possible with support from generous donors like you. We are grateful for your investment in research that will help to ensure that radiation oncology remains an integral part of cancer care and that all patients who could benefit from radiation therapy receive it. Every gift, whether it’s a registration for the 5K Run for the Future, an annual or monthly donation, or a Founders’ Circle pledge, helps the ROI to accomplish our mission to heighten the critical role of radiation therapy in the treatment of cancer through research and education. You can make a difference for radiation oncology by making your gift today. Thank you for supporting research that will personalize radiation therapy!
Deborah A. Kuban, MD, FASTRO
Colleen A. F. Lawton, MD, FASTRO